Novo Holdings is the holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation. Its operations are structured around two primary verticals: life science investments and a broader portfolio of financial assets. As of year-end 2024, the firm reported total assets under management (AUM) of DKK 1,060bn (approximately €142bn), positioning it as one of the largest life science investors globally by capital scale.
The firm's geographic footprint is concentrated in key global hubs for capital allocation and innovation: Copenhagen, London, San Francisco, Boston, Singapore, and Shanghai. This network provides deal-flow access across the US, European, and Asian markets. The organizational culture emphasizes recruiting from diverse backgrounds alongside a stated commitment to high performance grounded in respect and responsibility.
